866-997-4948(US-Canada Toll Free)

Global Vaccine Partnering Terms and Agreements 2014-2019: Deal trends, players and financials

Published By :

Current Partnering

Published Date : May 2019

Category :

Vaccines

No. of Pages : 350 Pages

The Global Vaccine Partnering Terms and Agreements 2014-2019: Deal trends, players and financials report provides comprehensive understanding and unprecedented access to the vaccine partnering deals and agreements entered into by the worlds leading healthcare companies.



Trends in vaccine and adjuvant partnering deals
Deal terms analysis
Partnering agreement structure
Partnering contract documents
Top deals by value
Most active dealmakers
Average deal terms for vaccines


This report contains a comprehensive listing of all vaccine partnering deals announced since January 2014, including financial terms where available, including over 450 links to online deal records of actual vaccine partnering deals as disclosed by the deal parties. In addition, where available, records include contract documents as submitted to the Securities Exchange Commission by companies and their partners.



The report takes readers through the vaccine deal trends, key players and top deal values allowing the understanding of how, why and under what terms companies are currently entering vaccine partnering deals.



The report presents average financial deal terms values for vaccine deals, where available listing by overall headline values, upfront payments, milestones and royalties enabling readers to analyse and benchmark the value of current deals.



The middle section of the report explores the leaders in the vaccine partnering field; both the leading deal values and leading players are reported allowing readers to see who is succeeding in this growing market. This chapter also looks at the contributions by the big pharma and big biotech companies of the world in terms of deals made.



One of the key highlights of the report is that over 450 online deals records of actual vaccine deals as disclosed by the deal parties are included towards the end of the report in a directory format that is easy to reference. Each deal links via Weblink to an online version and all these deals are organized by company A-Z, stage of development at signing, deal type (collaborative R&D, co-promotion, licensing etc), specific therapy and technology focus. In addition the report includes actual contract documents where available as submitted to the Securities Exchange Commission by companies and their deal partners.



Contract documents provide the answers to numerous questions about a prospective partners flexibility on a wide range of important issues, many of which will have a significant impact on each partys ability to derive value from the deal.



Finally the report concludes by looking into the future of vaccine partnering. With so many innovators looking for the next big thing in the field, the report selects companies to watch who are predicted to become big in the field based on their current dealmaking and financial trends.



Throughout the report various tables, figures and graphs are embedded in order to illustrate the trends and partnering activities of the vaccine field.



By the end of the report prospective dealmakers will have gained a thorough understanding of the partnering landscape of the vaccine market and will be familiar with the values and structures of the deals being signed within it.



Global Vaccine Partnering Terms and Agreements 2014-2019: Deal trends, players and financials is intended to provide the reader with an in-depth understanding and access to vaccine trends and structure of deals entered into by leading companies worldwide.



Global Vaccine Partnering Terms and Agreements 2014-2019: Deal trends, players and financials includes:



Trends in vaccine dealmaking in the biopharma industry since 2014
Analysis of vaccine deal structure
Access to headline, upfront, milestone and royalty data
Case studies of real-life vaccine deals
Access to over 450 vaccine deal documents
The leading vaccine deals by value since 2014
Most active vaccine dealmakers since 2014
The leading vaccine partnering resources


In Global Vaccine Partnering Terms and Agreements 2014-2019: Deal trends, players and financials, the available contracts are listed by:



Company A-Z
Headline value
Stage of development at signing
Deal component type
Therapy target
Specific technology type


Each deal title links via weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.



The Global Vaccine Partnering Terms and Agreements 2014-2019: Deal trends, players and financials report provides comprehensive access to available deals and contract documents for over 450 vaccine deals. Analyzing actual contract agreements allows assessment of the following:



What are the precise vaccine rights granted or optioned?
What is actually granted by the agreement to the partner company?
What exclusivity is granted?
What is the payment structure for the deal?
How are sales and payments audited?
What is the deal term?
How are the key terms of the agreement defined?
How are IPRs handled and owned?
Who is responsible for commercialization?
Who is responsible for development, supply, and manufacture?
How is confidentiality and publication managed?
How are disputes to be resolved?
Under what conditions can the deal be terminated?
What happens when there is a change of ownership?
What sublicensing and subcontracting provisions have been agreed?
Which boilerplate clauses does the company insist upon?
Which boilerplate clauses appear to differ from partner to partner or deal type to deal type?
Which jurisdiction does the company insist upon for agreement law?
Executive Summary



Chapter 1 Introduction



Chapter 2 Trends in Vaccines dealmaking



2.1. Introduction
2.2. Vaccines partnering over the years
2.3. Most active Vaccines dealmakers
2.4. Vaccines partnering by deal type
2.5. Vaccines partnering by therapy area
2.6. Deal terms for Vaccines partnering
2.6.1 Vaccines partnering headline values
2.6.2 Vaccines deal upfront payments
2.6.3 Vaccines deal milestone payments
2.6.4 Vaccines royalty rates



Chapter 3 Leading Vaccines deals



3.1. Introduction
3.2. Top Vaccines deals by value



Chapter 4 Most active Vaccines dealmakers



4.1. Introduction
4.2. Most active Vaccines dealmakers
4.3. Most active Vaccines partnering company profiles



Chapter 5 Vaccines contracts dealmaking directory



5.1. Introduction
5.2. Vaccines contracts dealmaking directory



Chapter 6 Vaccines dealmaking by technology type



Chapter 7 Partnering resource center



7.1. Online partnering
7.2. Partnering events
7.3. Further reading on dealmaking



Appendices



Appendix 1 Vaccines deals by company A-Z



Appendix 2 Vaccines deals by stage of development



Discovery
Preclinical
Phase I
Phase II
Phase III
Regulatory
Marketed
Formulation



Appendix 3 Vaccines deals by deal type



Asset purchase
Assignment
Bigpharma outlicensing
Co-development
Collaborative R&D
Co-market
Co-promotion
CRADA
Cross-licensing
Development
Distribution
Equity purchase
Evaluation
Grant
Joint venture
Licensing
Manufacturing
Marketing
Material transfer
Option
Promotion
Research
Settlement
Spin out
Sub-license
Supply
Technology transfer
Termination



Appendix 4 Vaccines deals by therapy area



Anaesthetics
Cardiovascular
Central Nervous System
Dental
Gastrointestinal
Hematology
Immunology
Infectives
Metabolic
Musculoskeletal
Oncology
Ophthalmics
Orphan disease
Pediatrics
Psychiatry
Respiratory



Appendix 5 Deal type definitions



About Wildwood Ventures



Current Partnering
Current Agreements
Recent report titles from Current Partnering



Table of figures



Figure 1: Vaccines partnering since 2014
Figure 2: Active Vaccines dealmaking activity since 2014
Figure 3: Vaccines partnering by deal type since 2014
Figure 4: Vaccines partnering by disease type since 2014
Figure 5: Vaccines deals with a headline value
Figure 6: Vaccines deals with an upfront value
Figure 7: Vaccines deals with a milestone value
Figure 8: Vaccines deals with a royalty rate value
Figure 9: Top Vaccines deals by value since 2014
Figure 10: Most active Vaccines dealmakers since 2014
Figure 11: Online partnering resources
Figure 12: Forthcoming partnering events

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *